NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Forecast, Predictions & Price Target

Analyst price target for ATHE

Based on 2 analysts offering 12 month price targets for Alterity Therapeutics Ltd

Min Forecast
$10.00+69.78%
Avg Forecast
$13.00+120.71%
Max Forecast
$16.00+171.65%

Should I buy or sell ATHE stock?

Based on 2 analysts offering ratings for Alterity Therapeutics Ltd.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATHE stock forecasts and price targets.

ATHE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-30
lockedlocked$00.00+00.00%2026-06-16

1 of 1

ATHE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHE$5.89$13.00+120.71%Strong Buy
ENGN$1.91$10.58+454.08%Buy
GUTS$0.81$5.50+582.38%Buy
SPRO$2.19N/AN/A
AARD$5.99$13.14+119.42%Buy

Alterity Therapeutics Stock Forecast FAQ

Is Alterity Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ATHE) stock is to Strong Buy ATHE stock.

Out of 2 analysts, 2 (100%) are recommending ATHE as a Strong Buy, 0 (0%) are recommending ATHE as a Buy, 0 (0%) are recommending ATHE as a Hold, 0 (0%) are recommending ATHE as a Sell, and 0 (0%) are recommending ATHE as a Strong Sell.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.

What is ATHE's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ATHE price target, the average ATHE price target is $13.00, with the highest ATHE stock price forecast at $16.00 and the lowest ATHE stock price forecast at $10.00.

On average, Wall Street analysts predict that Alterity Therapeutics's share price could reach $13.00 by Jun 30, 2027. The average Alterity Therapeutics stock price prediction forecasts a potential upside of 120.71% from the current ATHE share price of $5.89.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.